PAHO Vaccines

Vaccines pharmacovigilance dashboard

Diseases

Vaccines

Consolidated Information

Updates and Resources

All diseases

14 vaccines available in the dashboard

Chikungunya
COVID-19
Dengue
Measles, Mumps and Rubella
Mpox
Respiratory Syncytial Virus
Yellow fever

Disclaimer: This dashboard includes material compiled by PAHO from third-party sources. While PAHO has taken reasonable precautions to verify the information presented, it is distributed without a warranty of any kind. The reader is responsible for interpreting and using this information, and PAHO shall not be held liable for any damages arising from its use.

Filter by

Ixchiq chikungunya vaccine

Chikungunya

Alternative nameVLA1553

WHO authorization status:Eligible for prequalification

Countries authorization:

Manufacturer:Valneva Ltd.

Platform:Live attenuated vaccine

Pharmaceutical form:Powder and solvent for solution for injection

Administration route:

Intramuscular

Nº of doses and schedule:

Storage:

Countries Authorization5°C (41°F)

Comirnaty/Pfizer-BNT162b2 COVID-19 vaccine

COVID-19

Alternative nameComirnaty (original); tozinameran; BNT162b2
Variant-adapted vaccine names

Comirnaty Original/Omicron BA.1; tozinameran + riltozinameran; Comirnaty Original/Omicron BA.4-5; tozinameran + famtozinameran; Comirnaty Omicron XBB.1.5; raxtozinameran; Comirnaty JN.1, Comirnaty LP.8.1

WHO authorization status:Prequalified

Countries authorization:

Manufacturer:BioNTech Manufacturing GmbH, Germany

Platform:RNA-based vaccine

Pharmaceutical form:Dispersion for injection

Administration route:

Intramuscular

Nº of doses and schedule:

Storage:

Countries Authorization-75°C (-103°F)

Spikevax/Moderna COVID-19 vaccine

COVID-19

Alternative nameSpikevax (original); elasomeran; mRNA-1273; TAK-919
Variant-adapted vaccine names

Spikevax Bivalent Original/Omicron BA.1; elasomeran + imelasomeran; mRNA-1273.529; Spikevax Bivalent Original/Omicron BA.4-5; elasomeran + davesomeran; mRNA-1273.815; Spikevax XBB.1.5; andusomeran

WHO authorization status:Not prequalified

Countries authorization:

Manufacturer:Moderna TX, Inc., USA; Rovi Pharma Industrial Services S.A., Spain.

Platform:RNA-based vaccine

Pharmaceutical form:Dispersion for injection

Administration route:

Intramuscular

Nº of doses and schedule:

Storage:

Countries Authorization-20°C (-4°F)

CoronaVac/Sinovac COVID-19 vaccine

COVID-19

Alternative nameCoronaVac; adsorbed COVID-19 vaccine

WHO authorization status:Not prequalified

Countries authorization:

Manufacturer:Sinovac Life Sciences Ltd., China

Platform:Inactivated virus

Pharmaceutical form:Suspension for injection

Administration route:

Intramuscular

Nº of doses and schedule:

Storage:

Countries Authorization5°C (41°F)

Nuvaxovid - Novavax/Serum Institute of India COVID-19 vaccine

COVID-19

Alternative nameNuvaxovid; Covovax; NVX-CoV2373
Variant-adapted vaccine names

Nuvaxovid XBB.1.5; NVX-CoV2601

WHO authorization status:Prequalified

Countries authorization:

Manufacturer:Novavax, Czech Republic; Serum Institute of India Pvt. Ltd., India

Platform:Protein subunit

Pharmaceutical form:Dispersion for injection

Administration route:

Intramuscular

Nº of doses and schedule:

Storage:

Countries Authorization5°C (41°F)

Convidecia/CanSino COVID-19 vaccine

COVID-19

Alternative nameConvidecia; PakVac; Ad5-nCoV

WHO authorization status:Not prequalified

Countries authorization:

Manufacturer:CanSino Biologics Inc., China

Platform:Viral vector (non-replicating)

Pharmaceutical form:Suspension for injection

Administration route:

Intramuscular

Nº of doses and schedule:

Storage:

Countries Authorization5°C (41°F)

Corbevax COVID-19 vaccine

COVID-19

Alternative name‎BECOV-2

WHO authorization status:Emergency Use Listing (EUL)

Countries authorization:

Manufacturer:Biological E. Ltd., India

Platform:Recombinant protein subunit

Pharmaceutical form:Suspension for injection

Administration route:

Intramuscular

Nº of doses and schedule:

Storage:

Countries Authorization5°C (41°F)

Qdenga quadrivalent dengue vaccine

Dengue

Alternative nameTAK-003

WHO authorization status:Prequalified

Countries authorization:

Manufacturer:Takeda GmbH, Germany

Platform:Live attenuated vaccine

Pharmaceutical form:Powder and solvent for solution for injection

Administration route:

Subcutaneous

Nº of doses and schedule:

Storage:

Countries Authorization5°C (41°F)

Dengvaxia quadrivalent dengue vaccine

Dengue

Alternative nameCYD-TDV

WHO authorization status:Prequalified

Countries authorization:

Manufacturer:Sanofi Pasteur S.A., France

Platform:Live attenuated vaccine

Pharmaceutical form:Powder and solvent for suspension for injection

Administration route:

Subcutaneous

Nº of doses and schedule:

Storage:

Countries Authorization5°C (41°F)

Imvanex - Jynneos mpox vaccine

Mpox

Alternative nameImvamune; MVA-BN

WHO authorization status:Prequalified

Countries authorization:

Manufacturer:Bavarian Nordic, Denmark

Platform:Modified vaccinia virus Ankara

Pharmaceutical form:Suspension for injection

Administration route:

Subcutaneous

Nº of doses and schedule:

Storage:

Countries Authorization-20°C (-4°F)

LC16m8 mpox vaccine

Mpox

Alternative nameLC16; LC16 KMB

WHO authorization status:Emergency Use Listing (EUL)

Countries authorization:

Manufacturer:KM Biologics Co., Japan

Platform:Live attenuated vaccine

Pharmaceutical form:Freeze-dried powder

Administration route:

Percutaneous

Nº of doses and schedule:

Storage:

Countries Authorization5°C (41°F)

Abrysvo RSV vaccine

Respiratory Syncytial Virus

Alternative nameBivalent RSVpreF vaccine

WHO authorization status:Prequalified

Countries authorization:

Manufacturer:Pfizer Inc.

Platform:Recombinant protein subunit

Pharmaceutical form:Powder and solvent for solution for injection

Administration route:

Intramuscular

Nº of doses and schedule:

Storage:

Countries Authorization5°C (41°F)

Measles, mumps and rubella vaccine

Measles, Mumps and Rubella

Alternative nameTresivac, Measles, Mumps and Rubella Vaccine, Live, Attenuated
Variant-adapted vaccine names

Edmonston-Zagreb measles virus, Leningrad-Zagreb (L-Z) mumps virus and Wistar RA 27/3 rubella virus.

WHO authorization status:Prequalified

Countries authorization:

Manufacturer:Serum Institute of India Pvt. Ltd

Platform:Live attenuated vaccine

Pharmaceutical form:Freeze-dried powder

Administration route:

Subcutaneous

Nº of doses and schedule:

Storage:

Countries Authorization5°C (41°F)

STAMARIL yellow fever vaccine

Yellow fever

Alternative nameLive attenuated yellow fever vaccine, YF-VAX

WHO authorization status:Prequalified

Countries authorization:

Manufacturer:Sanofi Winthrop Industrie, France

Platform:Live attenuated vaccine

Pharmaceutical form:Powder and solvent for suspension for injection

Administration route:

Subcutaneous or intramuscular

Nº of doses and schedule:

Storage:

Countries Authorization5°C (41°F)
PAHO VaccinesCanada

The data, information and / or tools that PAHO makes available to users are provided without any kind of warranty, explicit or implicit. PAHO makes no guarantees nor will it be held responsible for the accuracy or veracity of the data, information and / or tools provided. PAHO may modify these periodically without prior notice. Users must use these data, information and / or tools at their own risk and expense. In no case will PAHO be responsible for damages and / or losses derived from or related to the use of these data, information and / or tools even when they could have been warned and / or prevented. PAHO reserves the right to modify or discontinue any data, information and / or tools that it makes available to its users through this site, with or without prior notice.

© Pan American Health Organization. All rights reserved.